Pharos iBio Co., Ltd.

₩5,500As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:388870Healthcare
Country South Korea
PE (Fwd) •••
TSR 3Y CAGR (25.73%)
Div yield —
ROE (83.69%)
Pharmaceutical Preparations
Beta (5Y) (0.29)
PE TTM —
TSR TTM 12.82%
Mkt cap ₩71.20B
ROIC (41.53%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩6,659
21.07%
(93.31%)
Hold 5|5|10|9|5
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
121.06
118.94
132.38
145.81
8.08%
8.32%
18.35%
32.13%
Revenue₩B
5.601
5.782
5.922
6.046
1.83%
5.14%
10.04%
11.11%
Peers (US$52.50M)
Cap (US$)
PE
57.85M
8.731x
52.57M
21.04x
Capital
TTM
5Y
10Y
Leveragex
1.532
1.159
0.830
EBIT/Intx
1.364
0.146
0.136
Own earn%
(11.97)
(28.84)
(41.43)
Sh yield%
30.86
25.37
25.28
Owners
Insiders/Inst%
7.53
84.48
Short interest%
0.96
SBC / revenue%
5.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
4–13
$1 testx
0.0
Incr. ROIC%
2